Skip to main content
Top

17-02-2016 | Ophthalmologic cancers | Article

A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma

Journal: Pediatric Radiology

Authors: Emily Wyse, James T. Handa, Alan D. Friedman, Monica S. Pearl

Publisher: Springer Berlin Heidelberg

Abstract

Retinoblastoma is a malignancy of the retina that usually presents before the age of 5 years. Sporadic retinoblastoma is most often unilateral and with no hereditary influence, whereas familial retinoblastoma presents unilaterally or bilaterally in conjunction with genetic inheritance. Several treatments have been attempted with the goals of saving the child’s life, salvaging the eye, and preserving vision. Alternative methods including external beam radiation, systemic chemotherapy and focal therapies have been shown to be effective but carry a risk of enucleation and other complications proportional to the severity of the tumor. Selective intra-arterial chemotherapy for retinoblastoma began in 1988 in Japan and has emerged in the last 7 years in the United States as a feasible, effective and minimally invasive treatment option. We review the retinoblastoma treatment literature focusing on intra-arterial chemotherapy.
Literature
1.
Aerts I, Lumbroso-Le Rouic L, Gauthier-Villars M et al (2006) Retinoblastoma. Orphanet J Rare Dis 1:31CrossRefPubMedPubMedCentral
2.
Abdolahi A, van Wijngaarden E, McClean MD et al (2013) A case-control study of paternal occupational exposures and the risk of childhood sporadic bilateral retinoblastoma. Occup Environ Med 70:372–379CrossRefPubMedPubMedCentral
3.
Broaddus E, Topham A, Singh AD (2009) Survival with retinoblastoma in the USA: 1975–2004. Br J Ophthalmol 93:24–27CrossRefPubMed
4.
Jabbour P, Chalouhi N, Tjoumakaris S et al (2012) Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma. J Neurosurg Pediatr 10:175–181CrossRefPubMed
5.
Reese AB, Ellsworth RM (1964) Management of retinoblastoma. Ann N Y Acad Sci 114:958–962CrossRef
6.
Shields CL, Mashayekhi A, Au AK et al (2006) The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 113:2276–2280CrossRefPubMed
7.
Chantada G, Doz F, Antoneli CB et al (2006) A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer 47:801–805CrossRefPubMed
8.
Hamel P, Heon E, Gallie BL et al (2000) Focal therapy in the management of retinoblastoma: when to start and when to stop. J AAPOS 4:334–337CrossRefPubMed
9.
Kim JW, Abramson DH, Dunkel IJ (2007) Current management strategies for intraocular retinoblastoma. Drugs 67:2173–2185CrossRefPubMed
10.
Wong FL, Boice JD Jr, Abramson DH et al (1997) Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 278:1262–1267CrossRefPubMed
11.
Kleinerman RA, Tucker MA, Tarone RE et al (2005) Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 23:2272–2279CrossRefPubMed
12.
Foote RL, Garretson BR, Schomberg PJ et al (1989) External beam irradiation for retinoblastoma: patterns of failure and dose-response analysis. Int J Radiat Oncol Biol Phys 16:823–830CrossRefPubMed
13.
Zelter M, Damel A, Gonzalez G et al (1991) A prospective study on the treatment of retinoblastoma in 72 patients. Cancer 68:1685–1690CrossRefPubMed
14.
Shidnia H, Hornback NB, Helveston EM et al (1977) Treatment results of retinoblastoma at Indiana University Hospitals. Cancer 40:2917–2922CrossRefPubMed
15.
Sethi RV, Shih HA, Yeap BY et al (2014) Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer 120:126–133CrossRefPubMed
16.
Shields CL, Shields JA, Needle M et al (1997) Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology 104:2101–2111CrossRefPubMed
17.
Kingston JE, Hungerford JL, Madreperla SA et al (1996) Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 114:1339–1343CrossRefPubMed
18.
Reese AB, Hyman GA, Tapley ND et al (1958) The treatment of retinoblastoma by X-ray and triethylene melamine. AMA Arch Ophthalmol 60:897–906CrossRefPubMed
19.
Yamane T, Kaneko A, Mohri M (2004) The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol 9:69–73CrossRefPubMed
20.
Abramson DH, Dunkel IJ, Brodie SE et al (2008) A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 115:1398–1404CrossRefPubMed
21.
Abruzzo TA, Geller JI, Kimbrough DA et al (2015) Adjunctive techniques for optimization of ocular hemodynamics in children undergoing ophthalmic artery infusion chemotherapy. J Neurointerv Surg 7:770–776CrossRefPubMed
22.
Choi S, Han JW, Kim H et al (2013) Combined chemotherapy and intra-arterial chemotherapy of retinoblastoma. Korean J Pediatr 56:254–259CrossRefPubMedPubMedCentral
23.
Abramson DH, Dunkel IJ, Brodie SE et al (2010) Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology 117:1623–1629CrossRefPubMed
24.
Abramson DH, Francis JH, Dunkel IJ et al (2013) Ophthalmic artery chemosurgery for retinoblastoma prevents new intraocular tumors. Ophthalmology 120:560–565CrossRefPubMed
25.
Abramson DH, Marr BP, Dunkel IJ et al (2012) Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results. Br J Ophthalmol 96:499–502CrossRefPubMed
26.
Palioura S, Gobin YP, Brodie SE et al (2012) Ophthalmic artery chemosurgery for the management of retinoblastoma in eyes with extensive (>50%) retinal detachment. Pediatr Blood Cancer 59:859–864CrossRefPubMed
27.
Shields CL, Bianciotto CG, Jabbour P et al (2011) Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol 129:1399–1406CrossRefPubMed
28.
Thampi S, Hetts SW, Cooke DL et al (2013) Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution. Clin Ophthalmol 7:981–989CrossRefPubMedPubMedCentral
29.
Pearl MS, Torok C, Wang J et al (2015) Practical techniques for reducing radiation exposure during cerebral angiography procedures. J Neurointerv Surg 7:141–145CrossRefPubMed
30.
Shields CL, Kaliki S, Shah SU et al (2012) Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma. Ophthalmology 119:188–192CrossRefPubMed
31.
Bracco S, Leonini S, De Francesco S et al (2013) Intra-arterial chemotherapy with melphalan for intraocular retinoblastoma. Br J Ophthalmol 97:1219–1221CrossRefPubMed
32.
Abramson DH, Dunkel IJ, Brodie SE et al (2010) Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy. Arch Ophthalmol 128:370–372CrossRefPubMed
33.
Vajzovic L, Murray T, Aziz-Sultan M et al (2010) Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma. Clin Ophthalmol 5:6
34.
Peterson EC, Elhammady MS, Quintero-Wolfe S et al (2011) Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors. J Neurosurg 114:1603–1608CrossRefPubMed
35.
Shields CL, Kaliki S, Shah SU et al (2012) Effect of intraarterial chemotherapy on retinoblastoma-induced retinal detachment. Retina 32:799–804CrossRefPubMed
36.
Shields CL, Manjandavida FP, Lally SE et al (2014) Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the International Classification of Retinoblastoma. Ophthalmology 121:1453–1460CrossRefPubMed
37.
Venturi C, Bracco S, Cerase A et al (2013) Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments. Acta Ophthalmol 91:335–342CrossRefPubMed
38.
Gobin YP, Dunkel IJ, Marr BP et al (2011) Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol 129:732–737CrossRefPubMed
39.
Leahey A-M (2012) Systemic chemotherapy: a pediatric oncology perspective. In: Ramasubramanian A, Shields CL (eds) Retinoblastoma, 1st edn. Jaypee Brothers Medical Publishers, New Dehli, pp 81–85
40.
Venkatramani R, Jubran RF (2015) Retinoblastoma: intravenous chemotherapy. In: Singh A, Murphree A, Damato B (eds) Clinical ophthalmic oncology: retinoblastoma, 2nd edn. Springer, Heidelberg, pp 119–127
41.
Gombos DS, Hungerford J, Abramson DH et al (2007) Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor? Ophthalmology 114:1378–1383CrossRefPubMed
42.
Marees T, Moll AC, Imhof SM et al (2008) Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst 100:1771–1779CrossRefPubMed
43.
Campochiaro PA, Bryan JA 3rd, Conway BP et al (1986) Intravitreal chemotactic and mitogenic activity. Implication of blood-retinal barrier breakdown. Arch Ophthalmol 104:1685–1687CrossRefPubMed
44.
Eagle RC Jr, Shields CL, Bianciotto C et al (2011) Histopathologic observations after intra-arterial chemotherapy for retinoblastoma. Arch Ophthalmol 129:1416–1421CrossRefPubMed
45.
Abramson DH (2011) Benefits and risks of intraarterial chemotherapy for retinoblastoma: an update. Retina Today (November/December 2011):43–46